DrOlga Piskareva

Olga Piskareva delivers impact through both translational cancer research and educational innovation. Her research aims to improve outcomes for patients with neuroblastoma and lung cancer by discovering tumour-associated antigens and developing next-generation mRNA cancer vaccines.

In parallel, her educational leadership has shaped inclusive assessment and curriculum practices that promote student success, wellbeing, and equity for diverse learner populations across RCSI.